A rendering of Resilience's biomanufacturing site in Marlborough, MA that has been purchased by Oxford Properties Group (CNW Group/Oxford Properties Group Inc.)
February 17, 2023 03:21 PM EST
Deals
Pharma
Manufacturing

Ox­ford Prop­er­ties Group pur­chas­es Re­silience man­u­fac­tur­ing site for $125M

Tyler Patchen

News Reporter

The in­ter­na­tion­al re­al es­tate com­pa­ny Ox­ford Prop­er­ties Group has pur­chased a man­u­fac­tur­ing fa­cil­i­ty in the Boston sub­urbs.

Ac­cord­ing to Ox­ford, it has pur­chased a 120 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times